Hostname: page-component-54dcc4c588-gwv8j Total loading time: 0 Render date: 2025-09-11T06:11:23.775Z Has data issue: false hasContentIssue false

Efficacy of Step-by-Step (SbS) in Improving Depressive Symptoms and Functional Impairment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published online by Cambridge University Press:  26 August 2025

V. Astori*
Affiliation:
Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória
F. Pesente
Affiliation:
Universidade Federal do Espírito Santo, Vitória
G. de Oliveira e Souza
Affiliation:
Universidade Federal de Minas Gerais, Belo Horizonte
T. Y. Kimura
Affiliation:
Universidade Federal de Minas Gerais, Belo Horizonte
G. Coachman Hollenstein
Affiliation:
Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória
L. Pontes de Oliveira
Affiliation:
Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória
D. Fernandes Holanda
Affiliation:
Universidade Federal do Amazonas, Manaus, Brazil
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The growing need for effective solutions to bridge the mental health treatment gap is particularly critical in countries where economic and political crises have exacerbated existing mental health challenges. In this context, the urgency for scalable and accessible interventions is evident. Step-by-Step (SbS), a guided digital self-help program developed by the World Health Organization (WHO), has been implemented as a promising approach to alleviate depressive symptoms and improve functionality in vulnerable populations.

Objectives

This meta-analysis aims to evaluate the findings of studies that examined the efficacy of SbS, compared with enhanced care as usual (ECAU), in reducing depressive symptoms and functional impairment.

Methods

We systematically searched PubMed, Cochrane, and Scopus for randomized controlled trials (RCTs) comparing SbS with ECAU. The pooled outcomes were the overall improvement in depressive symptoms, measured by the Patient Health Questionnaire (PHQ-9), as well as functional impairment measured by the WHO Disability Assessment Schedule-12 (WHODAS). We calculated the mean difference (MD) for the outcomes, with 95% confidence intervals (CIs). Statistical analysis was performed using Review Manager (RevMan) 8.1.1 with a fixed-effect model. Heterogeneity was assessed using the I² statistic.

Results

Three RCTs were included, encompassing 604 patients, of whom 263 (43.5%) participated in SbS. The population consisted of 35.1% males and 64.9% females. The mean age was 28.8 years, with a standard deviation of 8.7. SbS reduced PHQ-9 scores (MD = -3.48; 95% CI [-4.44, -2.52]; P < 0.00001; I² = 3%; Figure 1) and WHODAS scores (MD = -3.37; 95% CI [-4.84, -1.90]; P < 0.00001; I² = 0%; Figure 2) compared with ECAU.

Image 1:

Image 2:

Conclusions

This meta-analysis of RCTs suggests that SbS has a positive effect in reducing depressive symptoms and functional impairment compared with ECAU.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.